|
|
 |
|
|
|
|
| Your Result on : Balance Sheet |
|
|
|
|
| Glenmark Pharmaceuticals Ltd |
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
|
|
|
|
| Book Value (Rs) |
|
| 868.3164333 |
|
|
|
|
|
|
Market Cap
(Rs In Cr.) |
|
| 51,685 |
|
|
|
|
|
|
|
|
|
|
|
|
| Year |
High (Rs) |
Low (Rs) |
Close (Rs) |
P/E High |
P/E Low |
P/E Close |
Mkt Cap.
(Rs In Cr.) |
| Jun 2025 |
1,758.00 |
1,448.50 |
1,753.10 |
34.91 |
27.76 |
34.72 |
49,472.62 |
| May 2025 |
1,471.05 |
1,340.35 |
1,457.75 |
29.81 |
25.31 |
28.87 |
41,137.82 |
| Apr 2025 |
1,585.60 |
1,336.95 |
1,380.55 |
32.27 |
26.38 |
27.34 |
38,959.23 |
| Mar 2025 |
1,546.65 |
1,275.10 |
1,540.05 |
30.76 |
24.55 |
30.50 |
43,458.39 |
| Feb 2025 |
1,552.95 |
1,274.70 |
1,278.75 |
31.01 |
25.16 |
25.32 |
36,084.81 |
| Jan 2025 |
1,658.20 |
1,368.00 |
1,452.50 |
33.17 |
26.47 |
28.76 |
40,987.83 |
| Share Prices Of
2024
|
| Dec 2024 |
1,620.95 |
1,447.00 |
1,608.85 |
32.34 |
27.33 |
31.86 |
45,399.84 |
| Nov 2024 |
1,776.00 |
1,451.80 |
1,528.00 |
35.31 |
28.20 |
30.26 |
43,118.35 |
| Oct 2024 |
1,830.05 |
1,625.10 |
1,693.30 |
36.75 |
31.43 |
33.53 |
47,782.92 |
| Sep 2024 |
1,773.95 |
1,610.60 |
1,673.60 |
35.78 |
31.60 |
33.14 |
47,227.01 |
| Aug 2024 |
1,750.00 |
1,360.05 |
1,734.85 |
34.96 |
25.87 |
34.35 |
48,955.41 |
| Jul 2024 |
1,473.75 |
1,229.60 |
1,468.25 |
29.29 |
23.65 |
29.07 |
41,432.28 |
| Jun 2024 |
1,264.50 |
1,050.00 |
1,230.65 |
25.48 |
19.49 |
24.37 |
34,727.49 |
| May 2024 |
1,183.25 |
985.60 |
1,160.75 |
23.50 |
19.12 |
22.99 |
32,754.99 |
| Apr 2024 |
1,098.00 |
958.00 |
1,056.15 |
22.28 |
18.52 |
20.91 |
29,803.30 |
| Mar 2024 |
974.05 |
883.50 |
957.50 |
19.66 |
16.48 |
18.96 |
27,019.52 |
| Feb 2024 |
941.65 |
766.65 |
925.85 |
17.09 |
12.98 |
16.55 |
26,126.39 |
| Jan 2024 |
922.25 |
842.25 |
909.70 |
16.72 |
14.09 |
16.26 |
25,668.84 |
| Share Prices Of
2023
|
| Dec 2023 |
857.95 |
772.70 |
854.00 |
15.41 |
13.71 |
15.27 |
24,097.16 |
| Nov 2023 |
799.90 |
702.05 |
779.80 |
14.59 |
11.55 |
13.94 |
22,003.47 |
|
| PREV |
NEXT
|
|
|
|
|
|
|
|
|
|